Design and evaluation of ciprofloxacin hydrochloride ocular inserts

International Journal of PharmTech Research

Volumn 3, Issue 3, 2011, Pages 1750-1763

  Attia, Mohamed A ^a   Al Azizi, Mohamed ^a   Hashish, Mohamed S ^a  

^a German University in Cairo GUC   (Egypt)

Author keywords

In vivo study; Mechanical properties; Ocular inserts; Permeation; Release study

Indexed keywords

CIPROFLOXACIN; EUDRAGIT RS; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE; POLYMER; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONJUNCTIVITIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG PENETRATION; DRUG SCREENING; EYE; IN VIVO STUDY; KERATITIS; NONHUMAN; OCULAR INSERT; PHYSICAL CHEMISTRY; RABBIT; SUSTAINED DRUG RELEASE;

EID: 79961135205     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Attia, M. A., Kassem, M. A. and Safwat, S. M. In vivo performance of [3H]dexamethasone ophthalmic film delivery systems in the rabbit eye. International Journal of Pharmaceutics (1988) 47(1-3): 21-30.
2. Hume, L. R., H. K. Lee, L. Benedetti, Y. D. Sanzgiri, E. M. Topp and V. J. Stella. Ocular sustained delivery of prednisolone using hyaluronic acid benzyl ester films. International Journal of Pharmaceutics (1994) 111(3): 295-298.
3. B harath, S. and S. R. Hiremath. Ocular delivery systems of pefloxacin mesylate. Pharmazie (1999) 54(1): 55-8.
4. Maichuk, Y. F. Editorial: Ophthalmic drug inserts. Invest Ophthalmol (1975)14(2): 87-90.
5. Ozawa, H., S. Hosaka, T. Kunitomo and H. Tanzawa. Ocular inserts for controlled release of antibiotics. Biomaterials(1983) 4(3): 170-4.
6. Grass, G. M., J. Cobby and M. C. Makoid. Ocular delivery of pilocarpine from erodible matrices. J Pharm Sci (1984) 73(5): 618-21.
7. ®) for the treatment of external ocular infections in dogs. Journal of Controlled Release (2002) 85(1-3): 163-168.
8. O'Brien, T. P., M. G. Maguire, N. E. Fink, E. Alfonso and P. McDonnell. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol (1995) 113(10): 1257-65.
9. Bower, K. S., R. P. Kowalski and Y. J. Gordon. Fluoroquinolones in the treatment of bacterial keratitis. Am J Ophthalmol (1996) 121(6): 712-5.
10. Jauch, A., M. Fsadni and G. Gamba. Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis. Graefes Arch Clin Exp Ophthalmol (1999) 237(9): 705-13.
11. Thibodeaux, B. A., J. J. Dajcs, A. R. Caballero, M. E. Marquart, D. O. Girgis and R. J. O'Callaghan.Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis. Curr Eye Res (2004) 28(5): 337-42.
12. Chalita, M. R., A. L. Hofling-Lima, A. Paranhos, P. Schor and R. Belfort, Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years.Am J Ophthalmol (2004) 137(1): 43-51.
13. Whiteley, H. E., R. L. Peiffer, M. H. Wanda, G. R. Colin and A. W. Matthew. The Eye. Handbook of Toxicologic Pathology (Second Edition). San Diego, Academic Press: (2002) 539-584.
14. Gorle, A. P. and S. G. Gattani. Design and evaluation of polymeric ocular drug delivery system. Chem Pharm Bull (Tokyo) (2009) 57(9): 914-9.
15. Gilhotra, R. M. and D. N. Mishra. Alginate-chitosan film for ocular drug delivery: effect of surface cross-linking on film properties and characterization. Pharmazie (2008) 63(8): 576-9.
16. Mosher, G. L. and T. J. Mikkelson. Permeability of the n-alkyl p-aminobenzoate esters across the isolated corneal membrane of the rabbit. International Journal of Pharmaceutics (1979) 2(3-4): 239-243.
17. Peyman, G. A., J. T. Paque, H. I. Meisels and T. O. Bennett. Postoperative endophthalmitis: a comparison of methods for treatment and prophlaxis with gentamicin. Ophthalmic Surg (1975) 6(1): 45-55.
18. Yang, L. and A. T. Paulson. Mechanical and water vapour barrier properties of edible gellan films. Food Research International (2000) 33: 563-570.
19. Arvanitoyannis, I. S., A. Nakayama and S. I. Aiba. Chitosan and gelatin based edible films: state diagrams, mechanical and permeation properties. Carbohydrate Polymers (1998)37: 371-382.
20. Sothornvit, R. and J. M. Krochta. Plasticizer effect on oxygen permeability of beta-lactoglobulin films. J Agric Food Chem (2000) 48(12): 6298-302.
21. Eduardo, P. A., D. P. S. Tásia, V. M. N. Marco, C. M. Aldo, F. G. Marconi and N. R. Fernanda. Mechanical properties and release studies of chitosan films impregnated with silver sulfadiazine. Journal of Applied Polymer Science (2006) 102(4): 3462-3470.
22. Kevin, C. G., J. S. Anil and H. S. Pratik. Formulation and in - vitro characterization of monolithic matrix transdermal systems using HPMC/Eudragit S 100 polymer blends. International Journal of Pharmacy and Pharmaceutical Sciences (2009) 1(1): 108-120.
23. Okor, R. S. Influence of hydrophilic character of plasticizer and polymer on certain film properties. International Journal of Pharmaceutics (1982)11(1): 1-9.
24. Remuñán-López, C. and R. Bodmeier. Mechanical, water uptake and permeability properties of crosslinked chitosan glutamate and alginate films. Journal of Controlled Release (1997) 44(2-3): 215-225.
25. Myllärinen, P., R. Partanen, J. Seppälä and P. Forssell. Effect of glycerol on behaviour of amylose and amylopectin films. Carbohydrate Polymers (2002) 50(4): 355-361.
26. Tanwar, Y. S., C. S. Chauhan and A. Sharma. Development and evaluation of carvedilol transdermal patches. Acta Pharm (2007) 57(2): 151-9.
27. ® Microspheres of Stavudine. Tropical Journal of Pharmaceutical Research (2005)4(1): 369-75.
28. Rao, V. and S. Shyale. Preparation and Evaluation of Ocular Inserts Containing Norfloxacin. Turkish Journal of Medical Sciences (2004) 34(4): 239-46.
29. Ciulla, T. A., M. B. Starr and S. Masket. Bacterial endophthalmitis prophylaxis for cataract surgery: An evidence-based update. Ophthalmology (2002) 109(1): 13-24.
30. Leibowitz, H. M. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol (1991) 112(4 Suppl): 34S-47S.
31. Hyndiuk, R. A., R. A. Eiferman, D. R. Caldwell, G. O. Rosenwasser, C. I. Santos, H. R. Katz, S. S. Badrinath, M. K. Reddy, J. P. Adenis and V. Klauss. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology (1996) 103(11): 1854-62; discussion 1862-3.
32. Adebayo, A., J. Parikh, S. McCormick, M. Shah, R. Huerto, G. Yu and T. Milman. Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary. Graefe's Archive for Clinical and Experimental Ophthalmology: (2010)1-9.
33. Darrell, R. W., S. M. Modak and C. L. Fox, Jr. Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit. Trans Am Ophthalmol Soc. (1984) 82: 75-91.
34. Hobden, J. A., J. J. Reidy, R. J. O'Callaghan, M. S. Insler and J. M. Hill. Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis. Invest Ophthalmol Vis Sci (1990) 31(11): 2241-3.
35. Kim, I. T., K. H. Chung and B. S. Koo. Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis. Korean J Ophthalmol (1996) 10(1): 8-17.